XML 30 R14.htm IDEA: XBRL DOCUMENT
v3.26.1

FAIR VALUE MEASUREMENTS | 6 Months Ended
--- | ---
Jun. 30, 2026
Fair Value Disclosures [Abstract] |
FAIR VALUE MEASUREMENTS | FAIR VALUE MEASUREMENTS The following tables present information on the financial assets and liabilities measured and recorded at fair value on a recurring basis as of June 30, 2026 and December 31, 2025.
| Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis as of June 30, 2026 Using
| Fair value as of June 30, 2026 |  | Quoted prices in active markets for identical assets (Level 1) |  | Other observable inputs (Level 2) |  | Significant unobservable inputs (Level 3)
Assets: |  |  |  |  |  |  |
Securities and other investments owned: |  |  |  |  |  |  |
Equity securities | $ | 541,444 |  |  | $ | 432,120 |  |  | $ | 276 |  |  | $ | 109,048 |
Partnership interests and other investments | 83,026 |  |  | — |  |  | — |  |  | 83,026 |
Corporate bonds | 28,166 |  |  | — |  |  | 28,166 |  |  | — |
Other fixed income securities | 5,175 |  |  | 4,973 |  |  | 202 |  |  | — |
Total securities and other investments owned | 657,811 |  |  | 437,093 |  |  | 28,644 |  |  | 192,074 |
Loans receivable, at fair value | 38,802 |  |  | — |  |  | — |  |  | 38,802 |
Total assets measured at fair value | $ | 696,613 |  |  | $ | 437,093 |  |  | $ | 28,644 |  |  | $ | 230,876 |
Liabilities: |  |  |  |  |  |  |
Securities sold not yet purchased: |  |  |  |  |  |  |
Equity securities | $ | 8,894 |  |  | $ | 8,593 |  |  | $ | 301 |  |  | $ | — |
Corporate bonds | 593 |  |  | — |  |  | 593 |  |  | — |
Total securities sold not yet purchased | 9,487 |  |  | 8,593 |  |  | 894 |  |  | — |
Embedded derivatives, included in accrued expenses and other liabilities | 797 |  |  | — |  |  | — |  |  | 797 |
Total liabilities measured at fair value | $ | 10,284 |  |  | $ | 8,593 |  |  | $ | 894 |  |  | $ | 797 |
| Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis at December 31, 2025 Using
| Fair value at December 31, 2025 |  | Quoted prices in active markets for identical assets (Level 1) |  | Other observable inputs (Level 2) |  | Significant unobservable inputs (Level 3)
Assets: |  |  |  |  |  |  |
Securities and other investments owned: |  |  |  |  |  |  |
Equity securities | $ | 304,422 |  |  | $ | 233,199 |  |  | $ | — |  |  | $ | 71,223 |
Partnership interests and other investments | 40,082 |  |  | — |  |  | — |  |  | 40,082 |
Corporate bonds | 31,751 |  |  | — |  |  | 31,751 |  |  | — |
Other fixed income securities | 4,373 |  |  | 2,957 |  |  | 1,416 |  |  | — |
Total securities and other investments owned | 380,628 |  |  | 236,156 |  |  | 33,167 |  |  | 111,305 |
Loans receivable, at fair value | 26,303 |  |  | — |  |  | — |  |  | 26,303 |
Total assets measured at fair value | $ | 406,931 |  |  | $ | 236,156 |  |  | $ | 33,167 |  |  | $ | 137,608 |
Liabilities: |  |  |  |  |  |  |
Securities sold not yet purchased: |  |  |  |  |  |  |
Equity securities | $ | 9,342 |  |  | $ | 9,342 |  |  | $ | — |  |  | $ | — |
Corporate bonds | 467 |  |  | — |  |  | 467 |  |  | — |
Total securities sold not yet purchased | 9,809 |  |  | 9,342 |  |  | 467 |  |  | — |
Liability-classified warrants | 6,400 |  |  | — |  |  | — |  |  | 6,400 |
Total liabilities measured at fair value | $ | 16,209 |  |  | $ | 9,342 |  |  | $ | 467 |  |  | $ | 6,400 |
As of June 30, 2026 and December 31, 2025, financial assets measured and reported at fair value on a recurring basis and classified within Level 3 were $230,876 and $137,608, respectively, or 11.7% and 8.1%, respectively, of the Company’s total assets. In determining the fair value for these Level 3 financial assets, the Company analyzes various financial, performance and market factors to estimate the value, including where applicable, over-the-counter market trading activity. The fair value for individual Level 3 financial assets and liabilities have various financial inputs which include multiple of sales, multiple of EBITDA and indexes, the market price of related securities, annualized volatility, carried interest %, discount rates, recovery rates and expected term inputs that may change at each reporting period and result in an increase or decrease in the valuation of Level 3 financial assets and liabilities. The following tables summarize the significant unobservable inputs in the fair value measurement of Level 3 financial assets and liabilities by category of investment and valuation technique as of June 30, 2026 and December 31, 2025:
| Fair value at June 30, 2026 |  | Valuation Technique |  | Unobservable Input |  | Range |  | Weighted Average(1)
Assets: |  |  |  |  |  |  |  |  |
Equity securities | $ | 28,087 |  |  | Market approach |  | Multiple of EBITDA and indexes |  | 1.8x - 7.3x |  | 4.3x
|  |  |  |  | Multiple of sales |  | 0.7x - 8.5x |  | 2.2x
|  |  |  |  | Market price of related security |  | $10.32 - $12.01 |  | $10.70
| 80,040 |  |  | Monte Carlo simulation |  | Annualized volatility |  | 120.0% |  | 120.0%
| 921 |  |  | Option pricing model |  | Annualized volatility |  | 50.0% - 110.0% |  | 52.0%
Partnership interests and other investments | 83,026 |  |  | Market approach |  | Carried interest sharing |  | 15.0% - 46.3% |  | 33.1%
Loans receivable at fair value | 38,802 |  |  | Discounted cash flow |  | Discount rate |  | 6.8% - 93.7% |  | 36.0%
|  |  |  |  | Recovery rate |  | 35.9% |  | 35.9%
Total level 3 assets measured at fair value | $ | 230,876 |  |  |  |  |  |  |  |  |
Liabilities: |  |  |  |  |  |  |  |  |
Embedded derivatives, included in accrued expenses and other liabilities | $ | 797 |  |  | Discounted cash flow |  | Discount rate |  | 15.9% |  | 15.9%
|  |  | Monte Carlo simulation |  | Annualized volatility |  | 95.0% - 100.0% |  | 97.5%
Total level 3 liabilities measured at fair value | $ | 797 |  |  |  |  |  |  |  |  |
(1) Unobservable inputs were weighted by the relative fair value of the financial instruments.
| Fair value at December 31, 2025 |  | Valuation Technique |  | Unobservable Input |  | Range |  | Weighted Average(1)
Assets: |  |  |  |  |  |  |  |  |
Equity securities | $ | 25,572 |  |  | Market approach |  | Multiple of sales |  | 0.7x - 6.0x |  | 2.3x
|  |  |  |  | Market price of related security |  | $2.14 - $12.01 |  | $10.97
| 43,101 |  | Monte Carlo simulation |  | Annualized volatility |  | 120.0% - 148.0% |  | 121.0%
| 2,550 |  |  | Option pricing model |  | Annualized volatility |  | 46.0% - 115.0% |  | 57.0%
Partnership interests and other investments | 40,082 |  | Market approach |  | Discount rate |  | —% - 3.5% |  | 0.5%
|  |  |  |  | Market price of related security |  | $421.00 |  | $421.00
Loans receivable at fair value | 24,468 |  |  | Discounted cash flow |  | Discount rate |  | 6.8% - 56.5% |  | 21.0%
| 1,835 |  |  | Market approach |  | Market price of related security |  | $8.56 |  | $8.56
Total Level 3 assets measured at fair value | $ | 137,608 |  |  |  |  |  |  |  |  |
Liabilities: |  |  |  |  |  |  |  |  |
Liability-classified warrants | $ | 6,400 |  |  | Monte Carlo simulation and Black-Scholes option pricing model |  | Annualized volatility |  | 85.0% |  | 85.0%
|  |  |  |  | Discount for lack of marketability |  | 14.7% |  | 14.7%
Total Level 3 liabilities measured at fair value | $ | 6,400 |  |  |  |  |  |  |  |  |
(1) Unobservable inputs were weighted by the relative fair value of the financial instruments. The changes in Level 3 fair value hierarchy during the three months ended June 30, 2026 and 2025 were as follows:
| Equity Securities |  | Partnership Interests And Other Investments |  | Loans Receivable at Fair Value |  | Contingent Consideration |  | Liability-Classified Warrants(4) |  | Embedded Derivatives
Three Months Ended June 30, 2026 |  |  |  |  |  |  |  |  |  |  |
Level 3 balance at beginning of period | $ | 30,455 |  |  | $ | 52,650 |  |  | $ | 24,927 |  |  | $ | — |  |  | $ | 11,080 |  |  | $ | — |
Fair value adjustments(1) | 8,018 |  |  | — |  |  | 4,245 |  |  | — |  |  | 4,730 |  |  | 797 |
Relating to undistributed earnings | — |  |  | 30,376 |  |  | 233 |  |  | — |  |  | — |  |  | — |
Purchases/originations | 225,749 |  |  | — |  |  | 24,097 |  |  | — |  |  | — |  |  | — |
Settlements/repayments | (155,174) |  |  | — |  |  | (14,700) |  |  | — |  |  | (15,810) |  |  | — |
Level 3 balance at end of period | $ | 109,048 |  |  | $ | 83,026 |  |  | $ | 38,802 |  |  | $ | — |  |  | $ | — |  |  | $ | 797 |
Change in unrealized gains (losses)(2) | $ | 8,552 |  |  | $ | — |  |  | $ | 2,315 |  |  | $ | — |  |  | $ | — |  |  | $ | (797) |
Three Months Ended June 30, 2025 |  |  |  |  |  |  |  |  |  |  |
Level 3 balance at beginning of period | $ | 27,530 |  |  | $ | — |  |  | $ | 98,596 |  |  | $ | 4,593 |  |  | $ | 5,160 |  |  | $ | 14,593 |
Fair value adjustments(3) | 197 |  |  | 1,029 |  |  | 799 |  |  | 63 |  |  | (1,000) |  |  | (11,468) |
Purchases/originations | 24,998 |  |  | — |  |  | 624 |  |  | — |  |  | — |  |  | — |
Sales | — |  |  | — |  |  | (3,575) |  |  | — |  |  | — |  |  | — |
Settlements/repayments | (24,999) |  |  | — |  |  | (47,464) |  |  | (48) |  |  | — |  |  | (3,125) |
Level 3 balance at end of period | $ | 27,726 |  |  | $ | 1,029 |  |  | $ | 48,980 |  |  | $ | 4,608 |  |  | $ | 4,160 |  |  | $ | — |
Change in unrealized gains (losses)(2) | $ | 197 |  |  | $ | 1,029 |  |  | $ | 799 |  |  | $ | (63) |  |  | $ | 1,000 |  |  | $ | 11,468 |
(1) | Fair value adjustments during the three months ended June 30, 2026 include the following: $8,018 of realized and unrealized gains (losses) on equity securities is comprised of $4,946 included in “Trading gains, net” and $3,072 included in “Realized and unrealized gains (losses) on investments”, $30,376 of fees from investment income that has not yet been distributed from investment funds, $4,245 of fair value adjustments on loans included in “Fair value adjustments on loans”, $4,730 of realized losses related to liability-classified warrants included in “Change in fair value of financial instruments and other” line items in the accompanying unaudited condensed consolidated statements of operations.
(2) | For the three months ended June 30, 2026 and 2025, the change in unrealized gains (losses) is related to financial instruments held at the end of each respective reporting period.
(3) | Fair value adjustments during the three months ended June 30, 2025 include the following: $197 of realized and unrealized gains (losses) on equity securities comprised of $(92) included in “Trading gains, net” and $289 included in “Realized and unrealized gains (losses) on investments”, $799 of fair value adjustments on loans included in “Fair value adjustments on loans”, $1,029 of realized and unrealized gains related to other assets which is comprised of $902 recorded to “Trading gains, net” and $127 recorded to “Realized and unrealized gains (losses) on investments”, $(63) of realized and unrealized losses related to contingent consideration included in “Selling, general and administrative expenses”, $1,000 of unrealized gains related to liability-classified warrants included in “Change in fair value of financial instruments and other”, and $11,468 of unrealized gains related to embedded derivatives included in “Change in fair value of financial instruments and other” line items in the accompanying unaudited condensed consolidated statements of operations.
(4) | On May 28, 2026, immediately prior to exercise, the Oaktree Warrants were remeasured to fair value, resulting in a fair value of $15,810. This fair value represents the final measurement of the warrant liability immediately prior to settlement and does not reflect the subsequent gain recognized upon settlement of the Oaktree Warrants (see Note 22 – Stockholders’ Equity).
The changes in Level 3 fair value hierarchy during the six months ended June 30, 2026 and 2025 were as follows:
| Equity Securities |  | Partnership Interests And Other Investments |  | Loans Receivable at Fair Value |  | Contingent Consideration |  | Liability-Classified Warrants |  | Embedded Derivatives
Six Months Ended June 30, 2026 |  |  |  |  |  |  |  |  |  |  |
Level 3 balance at beginning of period | $ | 71,223 |  |  | $ | 40,082 |  |  | $ | 26,303 |  |  | $ | — |  |  | $ | 6,400 |  |  | $ | — |
Fair value adjustments(1) | 5,969 |  |  | — |  |  | 10,790 |  |  | — |  |  | 9,410 |  |  | 797 |
Relating to undistributed earnings | — |  |  | 42,944 |  |  | 717 |  |  | — |  |  | — |  |  | — |
Purchases/originations | 375,751 |  |  | — |  |  | 44,197 |  |  | — |  |  | — |  |  | — |
Settlements/repayments | (343,895) |  |  | — |  |  | (43,205) |  |  | — |  |  | (15,810) |  |  | — |
Level 3 balance at end of period | $ | 109,048 |  |  | $ | 83,026 |  |  | $ | 38,802 |  |  | $ | — |  |  | $ | — |  |  | $ | 797 |
Change in unrealized gains (losses)(2) | $ | 6,552 |  |  | $ | — |  |  | $ | 2,170 |  |  | $ | — |  |  | $ | — |  |  | $ | (797) |
Six Months Ended June 30, 2025 |  |  |  |  |  |  |  |  |  |  |
Level 3 balance at beginning of period | $ | 40,516 |  |  | $ | — |  |  | $ | 90,103 |  |  | $ | 4,538 |  |  | $ | — |  |  | $ | — |
Fair value adjustments(3) | (3,648) |  |  | 1,029 |  |  | (7,296) |  |  | 166 |  |  | (3,700) |  |  | (8,119) |
Purchases/originations | 25,867 |  |  | — |  |  | 58,632 |  |  | — |  |  | 7,860 |  |  | 11,244 |
Sales | (10,000) |  |  | — |  |  | (10,415) |  |  | — |  |  | — |  |  | — |
Settlements/repayments | (25,009) |  |  | — |  |  | (82,044) |  |  | (96) |  |  | — |  |  | (3,125) |
Level 3 balance at end of period | $ | 27,726 |  |  | $ | 1,029 |  |  | $ | 48,980 |  |  | $ | 4,608 |  |  | $ | 4,160 |  |  | $ | — |
Change in unrealized gains (losses)(2) | $ | (3,648) |  |  | $ | 1,029 |  |  | $ | (8,834) |  |  | $ | (166) |  |  | $ | 3,700 |  |  | $ | 8,119 |
(1) | Fair value adjustments during the six months ended June 30, 2026 include the following: $5,969 of realized and unrealized gains (losses) on equity securities comprised of $4,021 included in “Trading gains, net” and $1,948 of “Realized and unrealized gains (losses) on investments”, $42,944 of fees from investment income that has not yet been distributed from investment funds, $2,170 of fair value adjustments on loans included in “Fair value adjustments on loans”, $9,410 of realized losses related to liability-classified warrants included in “Change in fair value of financial instruments and other” line items in the accompanying unaudited condensed consolidated statements of operations.
(2) | For the six months ended June 30, 2026 and 2025, the change in unrealized gains (losses) is related to financial instruments held at the end of each respective reporting period.
(3) | Fair value adjustments during the six months ended June 30, 2025 include the following: $(3,648) of realized and unrealized gains (losses) on equity securities comprised of $(1,174) included in “Trading gains, net” and $(2,474) of “Realized and unrealized gains (losses) on investments”, $(7,296) of fair value adjustments on loans included in “Fair value adjustments on loans”, $1,029 of realized and unrealized gains related to other assets which is comprised of $902 recorded to “Trading gains (losses), net” and $127 recorded to “Realized and unrealized gains (losses) on investments”, $(166) of realized and unrealized losses related to contingent consideration included in “Selling, general and administrative expenses”, $3,700 of unrealized gains related to liability-classified warrants included in “Change in fair value of financial instruments and other”, and $8,119 of unrealized gains related to embedded derivatives included in “Change in fair value of financial instruments and other” line items in the accompanying unaudited condensed consolidated statements of operations.
Partnership and investment fund interests valued at NAV were $2,374 and $1,833 as of June 30, 2026 and December 31, 2025, respectively. Beginning in April 2025, the Company entered into purchase agreements with public companies that allow the counterparties to put their convertible preferred stock to the Company from time to time at its discretion (the “Written Puts”) (see Note 26 – Commitments and Contingencies). The Written Puts are recognized at fair value on a recurring basis within the “Accrued expenses and other liabilities” line item on the accompanying unaudited condensed consolidated balance sheets, with changes in fair value recognized in earnings. As of June 30, 2026 and December 31, 2025, the Company determined that the fair value of the Written Put liability was de minimis due to its discount to market prices being advantageous to the Company, and no liability or changes in earnings were recorded on the accompanying unaudited condensed consolidated balance sheets or accompanying unaudited condensed consolidated statements of operations. The Company holds the Written Puts as investments to advantageously monetize the underlying stock and provide capital raising activities for customers. The Company’s exposure is driven primarily by movements in the Issuer’s common stock price, the put writer’s credit by assumptions regarding the likelihood and timing of exercise and the April 2026 agreement which was amended to allow for the Issuer’s creditor to exercise the Written Put upon the Issuer’s Event of Default under the terms of its credit agreement. The amendment had a de minimis impact on the fair value of the Written Put. Assets and Liabilities Not Measured at Fair Value The carrying amounts reported in the unaudited condensed consolidated financial statements for cash and cash equivalents, restricted cash, accounts receivable, accounts payable and accrued expenses and other liabilities approximate fair value based on the short-term maturity of these instruments.
|  |  | June 30, 2026 |  | December 31, 2025
| Fair Value Hierarchy Level |  | Carrying Amount |  | Fair Value |  | Carrying Amount |  | Fair Value
Revolving credit facilities | Level 2 |  | $ | 31,316 |  |  | $ | 31,104 |  |  | $ | 6,638 |  |  | $ | 6,638 |
Term loans, net | Level 2 |  | $ | 115,770 |  |  | $ | 121,906 |  |  | $ | 119,297 |  |  | $ | 120,931 |
Senior notes payable | Level 2 |  | $ | 871,036 |  |  | $ | 734,696 |  |  | $ | 1,033,782 |  |  | $ | 681,890 |
New Notes payable | Level 3 |  | $ | 258,930 |  |  | $ | 202,511 |  |  | $ | 268,016 |  |  | $ | 166,796 |
The fair value of the Company's revolving credit facilities and term loans was estimated using a discounted cash flow approach, whereby contractual cash flows were discounted using current market interest rates and applicable credit spreads. The Company used a market approach for estimating the fair value of senior notes payable as they are listed and actively traded on the Nasdaq with sufficient frequency and volume to utilize quoted market prices. The fair value of the Company’s New Notes payable was estimated using a discounted cash flow approach, whereby contractual cash flows were discounted using a credit spread based on significant unobservable inputs, including the Company's estimated cost of borrowing of approximately 15.0%. Nonrecurring Fair Value Measurement The following table presents the carrying amounts of equity securities valued under the measurement alternative that were still held as of the balance sheet date for which a nonrecurring fair value measurement was recorded during the period:
| Fair Value |  | Level 2 |  | Level 3
As of June 30, 2026 |  |  |  |  |
Non-marketable equity securities measured using the measurement alternative | $ | 17,284 |  |  | $ | 17,284 |  |  | $ | — |
As of December 31, 2025 |  |  |  |  |
Non-marketable equity securities measured using the measurement alternative | $ | 13,867 |  |  | $ | 13,739 |  |  | $ | 128 |

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 107 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 100 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2E -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 940 -SubTopic 820 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration